Intellectual Property Owners Association
April 25, 2018
Partner Christopher Loh participated in IPO’s Biosimilar and Hatch-Waxman Litigation: Jurisdiction and Venue Issues Webinar on April 25th. He and his co-panelists addressed the following topics:
- Current developments in the law of personal jurisdiction and venue in Hatch-Waxman and BPCIA suits.
- Jurisdiction and venue issues that may arise in Hatch-Waxman and BPCIA suits when dealing with multiple defendants and foreign defendants.
- Recent developments that may affect a biosimilar maker’s choice of venue in certain declaratory judgment actions arising under the BPCIA.
- Recent developments concerning a biosimilar maker’s standing to challenge IPR decisions.